Scarica l'app Stockscreener
34.46
2.10%
-0.74
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché HRMY Giù?
Forum
Previsione
Precedente Chiudi:
$35.20
Aprire:
$35.2
Volume 24 ore:
693.07K
Relative Volume:
0.87
Capitalizzazione di mercato:
$1.99B
Reddito:
$899.11M
Utile/perdita netta:
$145.62M
Rapporto P/E:
13.88
EPS:
2.4829
Flusso di cassa netto:
$322.54M
1 W Prestazione:
+7.02%
1M Prestazione:
+14.30%
6M Prestazione:
-14.93%
1 anno Prestazione:
+3.39%
Intervallo 1D:
$34.32
$35.71
Intervallo di 1 settimana:
$32.00
$35.95
Portata 52W:
$25.52
$40.87
Harmony Biosciences Holdings Inc Stock (HRMY) Company Profile
Nome
Harmony Biosciences Holdings Inc
Settore
Industria
Telefono
(484) 539-9800
Indirizzo
630 W GERMANTOWN PIKE, PLYMOUTH MEETING
Compare HRMY vs VRTX, REGN, ARGX, ALNY, RVMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
HRMY
Harmony Biosciences Holdings Inc
|
34.46 | 1.99B | 899.11M | 145.62M | 322.54M | 2.4829 |
VRTX
Vertex Pharmaceuticals Inc
|
444.93 | 112.92B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
612.14 | 64.18B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
893.52 | 55.57B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
282.85 | 37.76B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
153.87 | 32.71B | 742.00K | -1.37B | -1.07B | -7.0731 |
Harmony Biosciences Holdings Inc Stock (HRMY) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-02-23 | Downgrade | Deutsche Bank | Buy → Hold |
| 2026-02-23 | Downgrade | Truist | Buy → Hold |
| 2026-02-11 | Ripresa | UBS | Neutral |
| 2025-07-21 | Iniziato | Truist | Buy |
| 2025-07-10 | Ripresa | Goldman | Neutral |
| 2025-06-02 | Ripresa | Oppenheimer | Outperform |
| 2025-02-11 | Iniziato | Deutsche Bank | Buy |
| 2024-12-17 | Iniziato | H.C. Wainwright | Buy |
| 2024-10-10 | Ripresa | Raymond James | Outperform |
| 2024-09-10 | Iniziato | UBS | Buy |
| 2024-06-21 | Iniziato | Citigroup | Buy |
| 2024-01-02 | Downgrade | BofA Securities | Neutral → Underperform |
| 2023-09-25 | Downgrade | Goldman | Neutral → Sell |
| 2023-09-07 | Iniziato | Berenberg | Buy |
| 2023-04-20 | Iniziato | BofA Securities | Neutral |
| 2022-10-14 | Aggiornamento | Janney | Neutral → Buy |
| 2022-10-14 | Aggiornamento | Jefferies | Hold → Buy |
| 2022-08-03 | Downgrade | Jefferies | Buy → Hold |
| 2022-07-13 | Downgrade | Goldman | Buy → Neutral |
| 2022-07-07 | Iniziato | Mizuho | Buy |
| 2022-04-14 | Iniziato | Cantor Fitzgerald | Overweight |
| 2021-12-01 | Iniziato | Oppenheimer | Outperform |
| 2021-11-04 | Iniziato | Raymond James | Outperform |
| 2021-09-23 | Iniziato | Needham | Buy |
| 2021-03-29 | Aggiornamento | Goldman | Neutral → Buy |
| 2020-09-14 | Iniziato | Goldman | Neutral |
| 2020-09-14 | Iniziato | Jefferies | Buy |
| 2020-09-14 | Iniziato | Piper Sandler | Overweight |
Mostra tutto
Harmony Biosciences Holdings Inc Borsa (HRMY) Ultime notizie
Wall Street analysts think Harmony Biosciences (HRMY) could surge 34.81%: Read this before placing a bet - MSN
Harmony Biosciences (HRMY) Stock Valuation After New Pitolisant Data And Reaffirmed Guidance - Yahoo Finance
Harmony Biosciences Announces Poster Presentations at 2026 SLEEP Annual Meeting - Investing News Network
Is Harmony Biosciences Holdings, Inc. (HRMY) A Good Stock To Buy Now? - Insider Monkey
Six narcolepsy and hypersomnia studies from Harmony at SLEEP 2026 - Stock Titan
Harmony Biosciences Holdings Inc at Goldman Sachs Healthcare Conference Transcript - GuruFocus
HRMY (NASDAQ) affiliate: option exercise 27,960 shares; Kapadia sells 54,646 - Stock Titan
HRMY Stock On Track For Best Intraday Gains In 18 Months — What Did Mizuho Analysts Say? - Stocktwits
HRMY affiliate files Rule 144 sale notice (NASDAQ: HRMY) for option exercises - Stock Titan
Sandip Kapadia files Form 144 proposing sale of 45,481 HRMY shares (HRMY) - Stock Titan
Technical Reactions to HRMY Trends in Macro Strategies - Stock Traders Daily
Looking Back at Stock Picks Hyatt Hotels, Sensient Technologies, Harmony Biosciences. What the Charts Say. -- Barrons.com - Moomoo
Harmony Biosciences Holdings (HRMY): One of the Best Stocks to Buy According to AI - Insider Monkey
HRMY or ARGX: Which is the better value stock right now? - MSN
Top 5 US Stocks To Buy In June 2026 - Investing.com
Harmony Biosciences to Participate in Upcoming Investor Conferences - Business Wire
Trading the Move, Not the Narrative: (HRMY) Edition - Stock Traders Daily
H.C. Wainwright reiterates Harmony Biosciences stock rating at buy By Investing.com - Investing.com South Africa
HRMY SEC FilingsHarmony Biosciences Holdings, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
H.C. Wainwright reiterates Harmony Biosciences stock rating at buy - Investing.com
H.C. Wainwright Reiterates Buy Rating on Harmony Biosciences Holdings Inc. (HRMY) - StreetInsider
Harmony Revenue Rises as WAKIX Franchise Expands - MyChesCo
Harmony Biosciences Reports Q1 Financial Results and Confirms 2026 Net Revenue Guidance of Over $1 Billion; Reinforces 2026 Strategic Priorities - Quantisnow
A beaten-down biotech just lost a meaningful backer — should you care? - AOL.com
A beaten-down biotech just lost a meaningful backer — should you care? - The Motley Fool
Harmony Biosciences Holdings, Inc.Common Stock (NQ: HRMY - FinancialContent
Harmony Biosciences (HRMY) director Germano Geno J files initial insider Form 3 - Stock Titan
Harmony Biosciences (HRMY) director receives 21,872-share stock option grant - Stock Titan
Harmony Biosciences director granted 21,872 options | HRMY Insider Trading - Stock Titan
Director Graf R. Mark receives 21,872 HRMY stock options in new equity grant - Stock Titan
Harmony Biosciences (HRMY) director awarded 21,872 stock options at $30.76 strike price - Stock Titan
Director Gary Sender receives 21,872 stock options at Harmony Biosciences (HRMY) - Stock Titan
Harmony Biosciences (HRMY) CMO exercises RSUs and covers tax withholding - Stock Titan
Harmony Biosciences (HRMY) CFO granted 164,309 stock options at $29.29 strike - Stock Titan
Harmony Biosciences (HRMY) CFO files initial Form 3 insider report - Stock Titan
Earnings Dip, Revenue Growth and Patent Moves Might Change The Case For Investing In Harmony Biosciences (HRMY) - simplywall.st
Number of shareholders of Harmony Biosciences Holdings, Inc. – NASDAQ:HRMY - TradingView
Harmony Biosciences Shareholders Approve Governance Measures at Meeting - TipRanks
Harmony Biosciences (HRMY) shareholders elect directors, ratify auditor and back pay - Stock Titan
TradingKey - TradingKey
Harmony Biosciences Holdings Inc Annual Shareholders Meeting Transcript - GuruFocus
Harmony Biosciences’ Four Key Pillars to Drive Value Creation - Sleep Review
Investors Can Find Comfort In Harmony Biosciences Holdings' (NASDAQ:HRMY) Earnings Quality - simplywall.st
Harmony Biosciences Holdings, Inc. 2026 Q1ResultsEarnings Call Presentation (NASDAQ:HRMY) 2026-05-13 - Seeking Alpha
(HRMY) Volatility Zones as Tactical Triggers - Stock Traders Daily
Analysts Offer Insights on Healthcare Companies: Harmony Biosciences Holdings (HRMY) and Liquidia Technologies (LQDA) - The Globe and Mail
Harmony Biosciences Holdings (HRMY) Announces Financial Results for Q1 2026 - Insider Monkey
H.C. Wainwright Maintains Harmony Biosciences(HRMY.US) With Buy Rating, Maintains Target Price $55 - Moomoo
Harmony Biosciences Holdings, Inc. Just Missed EPS By 21%: Here's What Analysts Think Will Happen Next - simplywall.st
Harmony Biosciences Holdings Inc Azioni (HRMY) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.04%
0.76%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):